Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol
HIT Consultant
NOVEMBER 30, 2022
A similar inflection point now faces the specialty pharmaceutical industry. The Institute of Medicine first advocated a shift from paper-based to electronic medical records in 1992 , yet only 13 percent of U.S. Visa’s attempted $5.3 billion in a Series D funding round in April 2022.
Let's personalize your content